By proceeding, you agree to our Terms of Use and Privacy Policy.
Ian Storer Head of Hit Discovery at AstraZeneca
Talks About #Strategy #Transformation
Preferred Locations #Europe
The 2-day programme addresses drug discovery in new modalities such as protein degradation, and case studies on the integration of screening approaches in phenotypic and genomics-based discovery, Organ-on-a-chip and 3D modelling.